Please assess the completion status of the following clinical trial:

Trial Title: Early Versus Delayed Intubation of Patients With COVID-19

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Adult patients with confirmed COVID-19 and severe acute hypoxemic respiratory failure~Exclusion Criteria:~* Postoperative acute respiratory failure (within one week from surgery)~* After cardiac arrest~* Chronic hypoxemic respiratory failure~* Hypercapnic respiratory failure~* No full code~* Lack of equipoise of the clinical team~* Lack of informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Early intubation (Type: ACTIVE_COMPARATOR): Patients with COVID-19 suffering from severe acute hypoxemic respiratory failure (defined as the need for non-rebreather mask or high flow nasal oxygen with setting FiO2 of at least 90% or non-invasive mechanical ventilation to maintain a SpO2 \>92%) for at least 48 hours will undergo intubation.
- Delayed intubation (Type: ACTIVE_COMPARATOR): Patients with COVID-19 suffering from severe acute hypoxemic respiratory failure (defined as the need for non-rebreather mask or high flow nasal oxygen with setting FiO2 of at least 90% or non-invasive mechanical ventilation to maintain a SpO2 \>92%) for at least 48 hours will continue to receive non-rebreather mask, high-flow nasal oxygen or non-invasive mechanical ventilation in an attempt to avoid intubation.

Based on this trial design, predict the completion outcome and termination type (if applicable).